J&J ties early-stage lymphoma CAR-T to 100% response rate in 10 patients

fiercebiotech.com/biotech/jj-hails-safety-100-objective-response-rate-10-patients-lymphoma-car-t

This story appeared on fiercebiotech.com, 2025-06-14 20:37:53.853000.
The Entire Business World on a Single Page. Free to Use →